Tag: fentanyl market report

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Fentanyl Market From 2025 to 2029?

The market size for fentanyl has seen significant expansion in the past few years. The market will increase from $16.22 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth in the historic period include the necessity for pain management, medical procedures and surgeries, managing pain in cancer patients, the growth of the opioid analgesic market, and an aging population.

Expectations are high for the fentanyl market to see robust expansion in the coming years, with projected growth to “$22.03 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.5%. This forecasted growth can be ascribed to factors such as rising instances of chronic pain, wider application of oncology treatments, increase in surgical procedures, public health campaigns, as well as regulatory greenlights for new medical uses. Key predicted trends for the forecast period involve breakthroughs in drug formulation technology, innovative strides in detecting usage, public health and harm reduction tactics, surge in pharmaceutical applications, and global cooperation and data exchange.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

What Elements Are Contributing To Growth In The Fentanyl Market?

The escalating occurrence of chronic ailments is anticipated to fuel the expansion of the fentanyl market in the future. Chronic illness refers to a health issue that lingers for an extended length of time, usually at least three months and frequently lasts throughout an individual’s lifetime. Fentanyl is primarily utilized in chronic illnesses to control severe, constant pain that other drugs or treatments fail to effectively manage. For example, according to the Heart Disease Facts issued by the US-based public health agency, the Centers for Disease Control and Prevention (CDC), in the United States in October 2024, coronary heart disease (CHD) caused 371,506 deaths in 2022, adding up to the total 702,880 heart disease deaths, which represented approximately one in every five deaths. Hence, the growing prevalence of chronic diseases is propelling the fentanyl market’s expansion.

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

What Trends Are Currently Influencing Growth In The Fentanyl Market?

Fentanyl market leaders like Indivior PLC have been working on innovative products like Opvee to increase their customer base, boost sales, and enhance revenues. Opvee (nalmefene) serves as a robust opioid receptor blocker intended to treat established or presumptive opioid overdoses caused by natural or synthetic opioids such as fentanyl. In May 2023, the U.S. Food and Drug Administration granted approval for Indivior PLC’s Opvee nasal spray. The spray works by counteracting the impact of opioids on the brain, aiding recently overdosed patients in regaining normal blood pressure and respiration. The ability to easily administer Opvee in nasal spray form during emergencies makes it an invaluable part of the arsenal of drugs used to fight opioid overdoses and save lives.

Who Are The Key Contributors To Growth In The Fentanyl Market?

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Region Is Projected To Lead The Fentanyl Market By 2025?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Fentanyl Market Size Shifted, And What Is the Outlook Through 2034?

There has been a robust growth in the market size of fentanyl in the preceding years. It is forecasted to expand from a worth of $16.22 billion in 2024 to a value of $17.15 billion in 2025, witnessing a compound annual growth rate (CAGR) of 5.7%. This upward trend in the historical stage can be linked to factors such as the requirement for pain management, medical interventions and surgeries, management of cancer-related pain, the rise in the opioid analgesic market, and the aging population.

Expectations for the fentanyl market size project a robust growth in the coming years, elevating to $22.03 billion by the year 2029, with a compound annual growth rate (CAGR) of 6.5%. The upward trend during the forecast period primarily correlates with the increasing incidences of chronic pain, the expansion in oncology treatments, a surge in surgical procedures, public health initiatives, and regulatory endorsements for new applications. Chief trends anticipated during the forecast period encompass advancements in drug compound formulations, technological innovations in its detection, public health and harm minimization strategies, a rise in pharmaceutical utilization, as well as international cooperation and data sharing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Fentanyl Market?

The rapid rise of chronic illnesses is forecasted to fuel the expansion of the fentanyl market. Chronic diseases are medical conditions that last for at least three months or longer and often persist throughout an individual’s lifetime. Fentanyl is commonly used in chronic diseases to treat severe, long-lasting pain that cannot be effectively managed by other medications or procedures. For example, the Heart Disease Facts report, released by the Centers for Disease Control and Prevention (CDC), an American public health organization, revealed in October 2024 that coronary heart disease (CHD) in the United States was accountable for 371,506 deaths in 2022. This accounted for approximately one in every five deaths from the total of 702,880 heart disease deaths. As such, the rising prevalence of chronic diseases is a key factor driving the growth of the fentanyl market.

Which Key Market Segments Comprise the Fentanyl Market and Drive Its Revenue Growth?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

Which Areas Are Leading Regions in the Fentanyl Market Expansion Across the Globe?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theFentanyl Market Over the Coming Years?

Key businesses in the fentanyl market, such as Indivior PLC, are creating groundbreaking products like Opvee and receiving necessary approvals to cater to a broad consumer base and generate increased sales and revenue. Opvee, which contains nalmefene, is a powerful antidote for known or potential opioid overdoses caused by natural or synthetic opioids, including fentanyl. In May 2023, Indivior PLC, stationed in the US, obtained authorization from the U.S. Food and Drug Administration for their Opvee nasal spray. This product functions by neutralizing the opioid effects on the brain, thus returning respiration and blood pressure of a recently overdosed patient back to normal levels. Opvee is easy to use in emergencies since it is administered as a nasal spray. Crucially, it forms part of a suite of medicines to potently address opioid overdoses and preserve lives.

View the full report here:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

How Is the Fentanyl Market Conceptually Defined?

Fentanyl refers to a synthetic opioid that is highly potent and used for pain relief and anesthesia purposes. It is used by doctors to alleviate extreme pain, particularly after surgery and in advanced-stage cancer. It is offered as transdermal patches or lozenges.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Fentanyl Market Growth in 2025?

The market size for fentanyl has seen significant growth in the past few years. It is projected to increase from $16.22 billion in 2024 to $17.31 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The surge during the historical period can be credited to the necessity for pain management, medical procedures and surgeries, management of pain related to cancer, growth in the opioid analgesic market, and an aging population.

What Is the Forecast for the Fentanyl Market Size Through 2029?

The marketplace for fentanyl is predicted to experience robust expansion in the upcoming years, with a projection to reach $22.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth in the prediction period include a surge in instances of chronic pain, the proliferation of cancer treatments, an increase in surgical procedures, public health measures, and regulatory endorsement for new therapeutic uses. Key trends anticipated during the forecast period consist of advancements in the formulation of drugs, innovations in detection technology, strategies for public health and harm reduction, a surge in applications in the pharmaceutical industry, and international cooperation and exchange of information.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

What are the Key Market Players in Fentanyl Market and How They’re Evolving?

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

What Are the Primary Growth Drivers in the Fentanyl Market?

The fentanyl market is seeing growth as the incidence of chronic illnesses rises. Chronic illnesses are those that persist for extended periods, often affecting a person throughout their entire life, usually lasting at least three months. One of the main uses of fentanyl in the treatment of chronic illnesses is to address intractable, severe pain that doesn’t respond to other remedies or procedures. For example, the Heart Disease Facts from the Centers for Disease Control and Prevention (CDC), a public health organization in the US, reported in October 2024 that coronary heart disease (CHD) caused 371,506 deaths in 2022. These deaths contributed to a total of 702,880 heart disease deaths, approximately 1 in every 5 deaths. Thus, the climb in chronic disease rates contributes to the expansion of the fentanyl market. The surge in demand for pain control is also predicted to stimulate the progress of the fentanyl market. Pain management, a medical field that concentrates on reducing pain to enhance the quality of life for patients, employs fentanyl as a powerful opioid that offers significant pain alleviation. It’s particularly effective for people with chronic or severe pain because it lowers pain levels, improves physical function, and treats the root causes of pain. A report from the Pain Relief Foundation, a charity based in the UK, in May 2022 showed that arthritis and musculoskeletal issues affect over 17 million UK citizens and result in 30 million lost workdays every year. Additionally, chronic pain afflicts up to 62% of individuals over 75, showing an increasing burden of pain as the population ages. This escalating need for effective pain management fuels the growth of the fentanyl market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

What Are the Leading Segments in the Global Fentanyl Industry?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

What Are the Key Market Trends in the Fentanyl Industry?

In an effort to increase their customer base, sales, and revenue, prominent businesses in the fentanyl market are focusing on the development of innovative products such as Opvee and achieving the necessary regulatory approvals. Opvee (nalmefene), a potent blocker of opioid receptors, is used to treat overdoses triggered by natural or synthetic opioids such as fentanyl. Indivior PLC, a pharmaceutical firm based in the U.S., is one such company that received U.S. Food and Drug Administration approval for Opvee nasal spray in May 2023. This product works by counteracting the effects of opioids on the brain, aiding patients who have recently overdosed to return their respiration and blood pressure to normal levels. Opvee, provided as a nasal spray, is easy to use in emergency situations and plays a crucial role in the array of medications used to address opioid overdoses, thereby saving lives.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

What Is the Regional Outlook for the Fentanyl Market?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237

This Report Delivers Insight On:

1. How big is the fentanyl market, and how is it changing globally?

2. Who are the major companies in the fentanyl market, and how are they performing?

3. What are the key opportunities and risks in the fentanyl market right now?

4. Which products or customer segments are growing the most in the fentanyl market?

5. What factors are helping or slowing down the growth of the fentanyl market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the fentanyl industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Fentanyl Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

The market size of fentanyl has seen significant growth in the past few years. The projection shows that it would escalate from a worth of $16.22 billion in 2024 to about $17.31 billion in 2025, yielding a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this expansion during the historic period include the demand for pain management, medical procedures and surgeries, cancer pain management, growth in the opioid analgesic market, and an aging population._x000D_

_x000D_

Forecasting a robust expansion in the forthcoming years, the fentanyl market is set to reach $22.31 billion by 2029, registering a compound annual growth rate (CAGR) of 6.5%. The projected increase in the forecast period can be linked to an escalation in chronic pain incidences, growth in oncology treatments, a surge in surgical procedures, public health initiatives, and regulatory approvals for new uses. Leading tendencies for the forecast period involve advancements in drug formulation technology, breakthroughs in detection technology, strategies for public health and harm reduction, a rise in pharmaceutical uses, as well as global cooperation and information exchange._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Fentanyl Market?#_x000D_

The fentanyl market is expected to see an upward trend, particularly due to the escalating number of chronic medical conditions. Chronic diseases, which are health conditions that extend over prolonged periods, often lifelong, and usually continuative for three months or more, make frequent use of fentanyl. This is mainly because of its pain management capabilities in intense, enduring pain situations where other medications and therapies fail to function optimally. In support of this, the Heart Disease Facts by the US’s public health agency, the CDC, highlighted that coronary heart disease (CHD) was the cause of 371,506 fatalities in 2022 in the United States. This was part of the overall 702,880 deaths due to heart diseases, contributing to approximately 20% of all deaths. Hence, the rising prevalence of chronic diseases is a significant driver of the fentanyl market’s growth. The anticipated growth of the fentanyl market is also fueled by an enhanced demand for pain management. The medical field of pain management is dedicated to reducing pain levels and improving the quality of life of patients. Fentanyl, being a potent opioid, provides considerable relief from pain, particularly for those afflicted with intense or chronic pain. It works by limiting pain levels, improving physical functionality, and addressing the root causes of pain. Supporting this, the UK-based Pain Relief Foundation reported in May 2022 that conditions like arthritis and musculoskeletal diseases impact over 17 million people in the UK, leading to the loss of 30 million workdays annually. Furthermore, chronic pain affects up to 62% of individuals aged over 75, suggesting a growing demand for pain management in an aging population. Therefore, the increasing demand for pain management serves as a driver for the expansion of the fentanyl market._x000D_

_x000D_

#Which Key Market Segments Comprise the Fentanyl Market and Drive Its Revenue Growth?#_x000D_

The fentanyl market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)_x000D_

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain_x000D_

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations_x000D_

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Fentanyl Market Expansion Across the Globe?#_x000D_

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Key Market Trends in theFentanyl Market Over the Coming Years?#_x000D_

Leading businesses in the fentanyl market are focusing on the creation of innovative products, such as Opvee, and securing approvals to expand their customer reach, boost sales, and ramp up revenue. Opvee (nalmefene), a powerful opioid receptor antagonist, is employed for the treatment of confirmed or suspected opioid overdoses caused by naturally or synthetically derived opioids, including fentanyl. For instance, in May 2023, the U.S.-based pharmaceutical enterprise, Indivior PLC, successfully acquired approval for Opvee nasal spray from the U.S. Food and Drug Administration. It works by inhibiting the influence of opioids on the brain, aiding in the recovery of patients who have suffered a recent overdose by restoring regular respiration and blood pressure. Opvee is provided through a nasal spray, which facilitates easy application in emergency situations. It forms a critical component of the medication spectrum used to tackle opioid overdoses and preserve lives._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report_x000D_

_x000D_

#How Is the Fentanyl Market Conceptually Defined?#_x000D_

Fentanyl refers to a synthetic opioid that is highly potent and used for pain relief and anesthesia purposes. It is used by doctors to alleviate extreme pain, particularly after surgery and in advanced-stage cancer. It is offered as transdermal patches or lozenges._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Fentanyl Market?

The escalating prevalence of chronic ailments is predicted to spur the progression of the fentanyl market. Chronic diseases are health conditions which last continuously for a substantial time, typically three consecutive months or more, and often remain throughout an individual’s lifetime. Fentanyl is applied in chronic diseases primarily for managing intense, relentless pain that cannot be effectively regulated by other medications or approaches. For example, as per the Heart Disease Facts released by the Centers for Disease Control and Prevention (CDC), a public health organization in the United States, in October 2024, coronary heart disease (CHD) caused 371,506 fatalities in 2022, contributing to the 702,880 total heart disease casualties that made up approximately one in every five deaths. Consequently, the escalating prevalence of chronic ailments is promoting the development of the fentanyl market. The fentanyl market is being propelled forward by the growing demand for pain management. Pain management is a branch of medicine devoted to alleviating pain and enhancing a patient’s life quality. Fentanyl is a highly potent opioid capable of delivering highly effective pain relief, especially for those suffering from extreme or chronic pain, by diminishing pain levels, improving physical function, and treating the root causes of pain. For instance, as per the Pain Relief Foundation, a charity in the UK, in May 2022, arthritis, and musculoskeletal conditions affect over 17 million individuals in the UK, and cause the loss of 30 million workdays per year, while chronic pain influences up to 62% of those over 75, demonstrating an expanding pain issue with an aging population. Hence, the fentanyl market’s growth is being driven by the increasing demand for pain management.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

#How Does the ProjectedFentanyl Market Growth Compare Over the Forecast Period?

The fentanyl market has seen robust growth over the past few years. The market is forecasted to rise from $16.22 billion in 2024 to $17.31 billion in 2025, accounting for a compound annual growth rate (CAGR) of 6.7%. This growth over the historic period is due to the demand for pain management, medical procedures and surgeries, cancer pain management, growth in the opioid analgesic market, and a surge in the aging population.

In the coming years, the market size of fentanyl is anticipated to experience robust growth. By 2029, the market is predicted to expand to a value of $22.31 billion with a 6.5% compound annual growth rate (CAGR). The impressive growth predicted for the forecast period can be linked to a variety of factors such as an increase in chronic pain cases, advancements in oncology treatments, an upsurge in surgical procedures, public health endeavors, and regulatory approvals for new usages. Major trends expected during this forecast period are advancements in drug formation technology, innovative detection tech, strategies for public health and harm reduction, an elevation in pharmaceutical applications, as well as international cooperation and the sharing of information.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237

What Are the Key Market Innovations in theFentanyl Market Over the Coming Years?

Fentanyl market leaders like Indivior PLC are introducing innovative offerings such as Opvee to attract a more extensive customer segment, boost sales, and enhance profit margins. Opvee (nalmefene) acts as a powerful blocker for opioid receptors and is utilized to address direct or suspicious opioid overdoses caused by organic or synthetic opioids such as fentanyl. In May 2023, the U.S. Food and Drug Administration gave Indivior PLC the green light to sell the Opvee nasal spray. The spray works by negating the impacts of opioids on the brain, assisting overdose patients in restoring their breathing and blood pressure to normal levels. Delivered as a nasal spray, Opvee is easy to use in emergency situations. Its importance is crucial in the portfolio of drugs used to fight opioid overdoses, ultimately saving lives.

Who Are the Top Companies Driving Innovation and Growth in theFentanyl Market?

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Key Market Segments Comprise the Fentanyl Market and Drive Its Revenue Growth?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

Which Regions Are Emerging as Leaders in the Fentanyl Market?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Fentanyl Market 2025, By The Business Research Company:

Myelodysplastic Syndrome Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/myelodysplastic-syndrome-global-market-report

Pheochromocytoma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Hemophilia Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Fentanyl Market Through 2034?

The market size of fentanyl has seen substantial growth in the past few years. It is projected to expand from $16.22 billion in 2024 to $17.31 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.7%. The past growth can be credited to aspects such as the need for pain management, medical procedures, surgeries, cancer pain control, the growth of the opioid analgesic market, and an aging population.

The market size for fentanyl is projected to experience significant growth in the coming years. With a compound annual growth rate (CAGR) of 6.5%, it’s expected to reach a value of $22.31 billion in 2029. The strong growth in the forecast period is primarily driven by an increase in cases of chronic pain, growing oncology therapies, rise in surgical procedures, advances in public health initiatives, and regulatory clearance for new indications. Key trends during the forecast period encompass progress in drug formulation technologies, breakthroughs in detection technologies, enhanced public health and harm reduction strategies, growth in pharmaceutical applications, as well as intensified international cooperation and information exchange.

Which Drivers Are Expected to Have the Greatest Impact on the fentanyl Market’s Growth?

The growth of the fentanyl market is likely to be driven by the rising prevalence of chronic diseases. Chronic diseases, a type of medical condition that lasts for a prolonged period, usually over three months and sometimes spanning a person’s lifetime, utilize fentanyl mainly to manage severe, constant pain that is not effectively diminshed by other treatments or interventions. For instance, the Heart Disease Facts, published by the US-based public health agency, Centers for Disease Control and Prevention (CDC), stated that in October 2024, coronary heart disease (CHD) led to 371,506 deaths in 2022 in the United States. This stat accounted for about one-fifth of the total 702,880 heart disease deaths. Thus, the rise in chronic diseases is contributing to an increased demand for fentanyl in the market.

Fentanyl Market Driver: Ascending Fentanyl Market Growth Led by Increased Need for Pain Management

 

Get Your Free Sample of the Global Fentanyl Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

Who Are the Major Industry Leaders Accelerating Growth in the Fentanyl Market?

Major companies operating in the fentanyl market report are:

• Pfizer Inc._x000D_

• Johnson & Johnson_x000D_

• Sinopharm Group_x000D_

• Merck & Co. Inc._x000D_

• Bayer AG_x000D_

Which Current Trends Are Having the Most Impact on the Fentanyl Market?

Leading corporations in the fentanyl market are innovating and creating products like Opvee, gaining necessary approvals with the objectives of expanding their customer reach, enhancing sales and boosting revenues. Opvee (nalmefene), a powerful opioid receptor antagonist, is utilized in the treatment of confirmed or suspected overdose cases caused by natural or synthetic opioids, including fentanyl. For example, in May 2023, the American pharmaceutical firm, Indivior PLC, achieved U.S. Food and Drug Administration approval for their Opvee nasal spray. This spray works by blocking the impact of opioids on the brain, thereby assisting patients who have recently overdosed to restore their respiration and blood pressure to normal. Opvee is dispensed through a nasal spray, making it convenient to use during emergencies. It holds a crucial spot in the arsenal of medicines used to fight opioid overdoses and preserve lives.

Get Instant Access to the Global Fentanyl Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

What Major Market Segments Define the Scope and Growth of the Fentanyl Market?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

Which Regions Are Key Players in the Growth of the Fentanyl Market?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Elements Shape the Definition of the Fentanyl Market?

Fentanyl refers to a synthetic opioid that is highly potent and used for pain relief and anesthesia purposes. It is used by doctors to alleviate extreme pain, particularly after surgery and in advanced-stage cancer. It is offered as transdermal patches or lozenges.

Browse Through More Similar Reports By The Business Research Company:

Myelodysplastic Syndrome Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/myelodysplastic-syndrome-global-market-report

Pheochromocytoma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Hemophilia Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: